Robeco Schweiz AG Has $155.37 Million Stock Holdings in Agilent Technologies, Inc. (NYSE:A)

Robeco Schweiz AG increased its stake in Agilent Technologies, Inc. (NYSE:A) by 1.6% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,156,536 shares of the medical research company’s stock after acquiring an additional 18,677 shares during the quarter. Agilent Technologies accounts for approximately 3.3% of Robeco Schweiz AG’s portfolio, making the stock its 3rd largest position. Robeco Schweiz AG owned approximately 0.40% of Agilent Technologies worth $155,369,000 as of its most recent SEC filing.

Other hedge funds also recently modified their holdings of the company. CKW Financial Group increased its stake in shares of Agilent Technologies by 114.9% in the 4th quarter. CKW Financial Group now owns 187 shares of the medical research company’s stock valued at $25,000 after acquiring an additional 100 shares in the last quarter. Global X Japan Co. Ltd. increased its stake in Agilent Technologies by 161.1% during the 4th quarter. Global X Japan Co. Ltd. now owns 188 shares of the medical research company’s stock valued at $25,000 after purchasing an additional 116 shares in the last quarter. Ashton Thomas Securities LLC bought a new stake in Agilent Technologies during the 3rd quarter valued at $31,000. Fortitude Family Office LLC increased its stake in Agilent Technologies by 68.3% during the 3rd quarter. Fortitude Family Office LLC now owns 234 shares of the medical research company’s stock valued at $35,000 after purchasing an additional 95 shares in the last quarter. Finally, RPg Family Wealth Advisory LLC bought a new stake in Agilent Technologies during the 3rd quarter valued at $38,000.

Insider Buying and Selling at Agilent Technologies

In other Agilent Technologies news, CEO Padraig Mcdonnell sold 1,911 shares of the company’s stock in a transaction dated Tuesday, January 21st. The shares were sold at an average price of $150.00, for a total transaction of $286,650.00. Following the sale, the chief executive officer now directly owns 39,652 shares of the company’s stock, valued at $5,947,800. This represents a 4.60 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

Analysts Set New Price Targets

A number of analysts have commented on the stock. JPMorgan Chase & Co. decreased their price target on shares of Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating for the company in a research note on Tuesday, November 26th. Citigroup boosted their price target on shares of Agilent Technologies to $165.00 and gave the company a “buy” rating in a research note on Thursday, December 19th. Wells Fargo & Company decreased their price target on shares of Agilent Technologies from $157.00 to $155.00 and set an “overweight” rating for the company in a research note on Monday, December 9th. Bank of America reduced their target price on shares of Agilent Technologies from $153.00 to $150.00 and set a “neutral” rating for the company in a research note on Friday, December 13th. Finally, Sanford C. Bernstein reduced their target price on shares of Agilent Technologies from $140.00 to $135.00 and set a “market perform” rating for the company in a research note on Tuesday, November 26th. Seven research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $144.38.

Agilent Technologies Price Performance

Shares of NYSE:A opened at $134.51 on Thursday. The company’s 50-day moving average is $140.90 and its 200 day moving average is $139.28. The company has a debt-to-equity ratio of 0.57, a quick ratio of 1.58 and a current ratio of 2.09. The company has a market capitalization of $38.37 billion, a P/E ratio of 30.43, a price-to-earnings-growth ratio of 3.63 and a beta of 1.07. Agilent Technologies, Inc. has a fifty-two week low of $124.16 and a fifty-two week high of $155.35.

Agilent Technologies (NYSE:A) last released its quarterly earnings data on Wednesday, February 26th. The medical research company reported $1.31 EPS for the quarter, beating the consensus estimate of $1.27 by $0.04. The business had revenue of $1.68 billion for the quarter, compared to the consensus estimate of $1.67 billion. Agilent Technologies had a net margin of 19.80% and a return on equity of 25.43%. On average, equities research analysts forecast that Agilent Technologies, Inc. will post 5.56 earnings per share for the current year.

Agilent Technologies Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 23rd. Shareholders of record on Tuesday, April 1st will be issued a dividend of $0.248 per share. This represents a $0.99 annualized dividend and a yield of 0.74%. The ex-dividend date is Tuesday, April 1st. Agilent Technologies’s dividend payout ratio (DPR) is presently 22.40%.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.